Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability of Healive and Havrix in Healthy Children
NCT01252680Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Apr 2010
- Primary completion
- Feb 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine (inactivated) in hepatitis A (HAV), sponsored by Sinovac Biotech Ltd.. Started Apr 2010; status: completed.
02
Drugs
hepatitis A vaccine (inactivated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01252680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252680.